FDA Choice For Tobacco Chief Suggests Bigger Role For Cessation Programs
This article was originally published in The Tan Sheet
Executive Summary
FDA's pick of Lawrence Deyton as the first director of the Center for Tobacco Products reveals smoking cessation may be a higher priority for the center than previously expected
You may also be interested in...
Tobacco Law Means Drug Sponsor Opportunities May Not Stop At Cessation
The tobacco control act prompts FDA to consider new indications - such as smoking reduction - for smoking cessation products, which could lead to new criteria for application approval
Tight 90-Day Countdown To Create Tobacco Center Poses Challenge To FDA
FDA has its work cut out for it to establish a Center for Tobacco Products within 90 days, once President Obama adds his promised signature to the bill giving the agency regulatory authority over tobacco
Tobacco Oversight Looks More Likely, But Is It Bad For FDA’s Health?
The likelihood of Congress handing FDA responsibility for regulating tobacco has ignited debate over whether the new purview would distract an already struggling agency from its mission